Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

NCT03560986 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

267

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Complex Regional Pain Syndrome (CRPS)

Interventions

DRUG: Neridronic acid 100 mg
DRUG: Placebo

Sponsor

Grünenthal GmbH